title: Effect of CGS 16949A plus tamoxifen on induced mammary tumours in rats.
abstract: The antitumour effect of CGS 16949A, an aromatase inhibitor, was investigated in rats with mammary tumours induced by 7,12-dimethylbenz[a]anthracene. A dose-dependent antitumour effect was observed after daily oral administration of CGS 16949A for 3 weeks. The tumour did not recur in the groups treated with 4.0 and 8.0 mg/kg per day. The complete remission rate increased and the time required to achieve complete remission became shorter with increasing daily doses. After daily administration for 3 weeks, a significant antitumour effect was observed in the group treated with CGS 16949A plus tamoxifen compared with that seen either with CGS 16949A or with tamoxifen alone. At the end of treatment, the group treated with CGS 16949A had significantly decreased oestradiol-17 beta and prolactin levels and increased levels of follicle stimulating hormone, but oestrone was not affected.
authors: Department of Surgery, Tokyo Metropolitan Komagome Hospital, Japan.
authors: T
authors: T
authors: Tominaga
authors: Y
authors: Y
authors: Yoshida
authors: K
authors: K
authors: Shimozuma
authors: K
authors: K
authors: Hayashi
authors: G
authors: G
authors: Kosaki
mesh_terms: D015127:9,10-Dimethyl-1,2-benzanthracene; D000818:Animals; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D004305:Dose-Response Relationship, Drug; D004958:Estradiol / Q000097:blood; D004965:Estrogen Antagonists / Q000627:therapeutic use*; D004970:Estrone / Q000097:blood; D017316:Fadrozole; D005260:Female; D005640:Follicle Stimulating Hormone / Q000097:blood; D007093:Imidazoles / Q000008:administration & dosage; D007986:Luteinizing Hormone / Q000097:blood; D008325:Mammary Neoplasms, Experimental / Q000097:blood / Q000139:chemically induced / Q000188:drug therapy*; D009570:Nitriles / Q000008:administration & dosage; D011388:Prolactin / Q000097:blood; D051381:Rats; D011919:Rats, Inbred Strains; D013629:Tamoxifen / Q000008:administration & dosage
chemical_list: D004965:Estrogen Antagonists; D007093:Imidazoles; D009570:Nitriles; D013629:Tamoxifen; D004970:Estrone; D004958:Estradiol; D015127:9,10-Dimethyl-1,2-benzanthracene; D011388:Prolactin; D007986:Luteinizing Hormone; D005640:Follicle Stimulating Hormone; D017316:Fadrozole